DexCom Inc. stock outperforms competitors on strong trading day
DexCom Inc. closed 38.30% below its 52-week high of $142.00, which the company achieved on March 26th.
DexCom Inc. stock underperforms Wednesday when compared to competitors
DexCom Inc. closed 39.13% short of its 52-week high of $142.00, which the company achieved on March 26th.
Samsung Reveals Ground-Breaking Blood Glucose Monitoring To Outdo Apple Watch
Glucose monitoring without piercing the skin is a prize companies like Apple and Samsung have been aiming for. Now, Samsung ...
Exchange Traded Concepts LLC Sells 1,526 Shares of DexCom, Inc. (NASDAQ:DXCM)
Exchange Traded Concepts LLC decreased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 12.4% in the ...
Flagship Harbor Advisors LLC Purchases Shares of 5,842 DexCom, Inc. (NASDAQ:DXCM)
Flagship Harbor Advisors LLC acquired a new stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) during the 4th quarter, ...
Samsung hints at non-invasive glucose tracking for its watches
Samsung's VP hinted at significant progress in developing non-invasive blood glucose tracking technology, potentially a ...
5 Key Insights On Dexcom’s Stelo And Abbott’s Lingo Glucose Monitors
Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...
WST, GXIG, STVN poised to benefit from Abbott's CGM growth
KeyBanc highlighted WST, GXIG, and STVN as the main beneficiaries following robust demand in the Continuous Glucose Monitoring (CGM) device market, as evidenced by Abbott Laboratories (NYSE:ABT)' ...